Spenda (ASX:SPX) has agreed to sell its invoice financing portfolio to Grapple for $2 million, subject to portfolio ...

The University of Queensland (UQ) and INOVIQ Ltd (ASX: IIQ) have joined forces to develop a groundbreaking blood test for ...

Savannah Goldfields Limited (ASX:SVG) has successfully completed its fully underwritten capital raising programme totalling ...

Aerometrex Limited (ASX:AMX) has commenced a strategic review of its business, led by Acting CEO Rob Veitch and supported by ...

Australian gold miner Auric Mining (ASX:AWJ) has reached a major milestone at its Jeffreys Find Gold Mine, with total gold ...

McPherson’s Limited (ASX:MCP) has begun its transition to a new operating model following a comprehensive review of its route ...

AustralianSuper, the country’s largest industry superannuation fund, has been fined $27 million by the Federal Court for ...

Westpac has partnered with Accenture to create advanced AI agents—referred to as agentic AI—that do more than just relay ...

US Markets US stocks tumbled on Friday amid fresh economic data that heightened fears of a slowing economy and stubborn ...

China continues to play a significant role in the rare earth market, yet the global landscape is undergoing notable changes.

In the first episode of a six-part interview series on immunotherapy, Mark Folke, CEO and Executive Director of Immutep (ASX:IMM), discusses the significance and rapid growth of immuno-oncology.

Mayfield Childcare Limited (ASX:MFD) has appointed Daniel Stone as its new Chief Executive Officer, effective April 8, 2025. Stone will replace outgoing CEO Ashok Naveinthiran, who retires on March 10 ...